CoChat

High-throughput screening with nanoimprinting 3D culture for efficient drug development by mimicking the tumor environment

Open access
Yoshii, Yukie, Furukawa, Takako, Waki, Atsuo, Okuyama, Hiroaki, Inoue, Masahiro, Itoh, Manabu, Zhang, Ming-Rong, Wakizaka, Hidekatsu, Sogawa, Chizuru, Kiyono, Yasushi, Yoshii, Hiroshi, Fujibayashi, Yasuhisa, Saga, Tsuneo · 2015 · Biomaterials
Cited by 66

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Anti-cancer drug development typically utilizes high-throughput screening with two-dimensional (2D) cell culture. However, 2D culture induces cellular characteristics different from tumors in vivo, resulting in inefficient drug development. Here, we report an innovative high-throughput screening system using nanoimprinting 3D culture to simulate in vivo conditions, thereby facilitating efficient drug development. We demonstrated that cell line-based nanoimprinting 3D screening can more efficiently select drugs that effectively inhibit cancer growth in vivo as compared to 2D culture. Metabolic responses after treatment were assessed using positron emission tomography (PET) probes, and revealed similar characteristics between the 3D spheroids and in vivo tumors. Further, we developed an advanced method to adopt cancer cells from patient tumor tissues for high-throughput drug screening with nanoimprinting 3D culture, which we termed Cancer tissue-Originated Uniformed Spheroid Assay (COUSA). This system identified drugs that were effective in xenografts of the original patient tumors. Nanoimprinting 3D spheroids showed low permeability and formation of hypoxic regions inside, similar to in vivo tumors. Collectively, the nanoimprinting 3D culture provides easy-handling high-throughput drug screening system, which allows for efficient drug development by mimicking the tumor environment. The COUSA system could be a useful platform for drug development with patient cancer cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biomaterials.2015.02.008

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 66

Metadata

Authors
Yoshii, Y., Furukawa, T., Waki, A., Okuyama, H., Inoue, M., Itoh, M., Zhang, M.-R., Wakizaka, H., Sogawa, C., Kiyono, Y., Yoshii, H., Fujibayashi, Y., & Saga, T.
Venue
Biomaterials
Publisher
Elsevier BV
Published
2015-05
Volume
51
Pages
278-289
ISSN
0142-9612 (ISSN-L)
OpenAlex
W2045416947
Cited by
66
References
9
FWCI
4.40
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High-throughput screening with nanoimprinting 3D culture for efficient drug development by mimicking the tumor environment. https://app.cochat.ai/papers/10.1016/j.biomaterials.2015.02.008
The paper
Yoshii, Y., Furukawa, T., Waki, A., Okuyama, H., Inoue, M., Itoh, M., Zhang, M.-R., Wakizaka, H., Sogawa, C., Kiyono, Y., Yoshii, H., Fujibayashi, Y., & Saga, T. (2015). High-throughput screening with nanoimprinting 3D culture for efficient drug development by mimicking the tumor environment. Biomaterials. https://doi.org/10.1016/j.biomaterials.2015.02.008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.